Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 743171, 13 pages
http://dx.doi.org/10.1155/2013/743171
Review Article

Experimental Evidence of -3 Polyunsaturated Fatty Acid Modulation of Inflammatory Cytokines and Bioactive Lipid Mediators: Their Potential Role in Inflammatory, Neurodegenerative, and Neoplastic Diseases

1Institute of General Pathology, School of Medicine, Catholic University, 00168 Rome, Italy
2Department of Physiology, National Taiwan University College of Medicine, Taipei 100, Taiwan
3Department of Gastroenterology, Hepatology and Endocrinology and Experimental and Clinical Research Center (ECRC), Charité University Medicine, 13353 Berlin, Germany

Received 1 February 2013; Revised 27 March 2013; Accepted 27 March 2013

Academic Editor: D. M. Clarke

Copyright © 2013 Gabriella Calviello et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Delgado-Lista, P. Perez-Martinez, J. Lopez-Miranda, and F. Perez-Jimenez, “Long chain omega-3 fatty acids and cardiovascular disease: a systematic review,” British Journal of Nutrition, vol. 107, no. 2, supplement, pp. S201–S213, 2012. View at Google Scholar
  2. S. J. Baum, P. M. Kris-Etherton, W. C. Willett et al., “Fatty acids in cardiovascular health and disease: a comprehensive update,” Journal of Clinical Lipidology, vol. 6, no. 3, pp. 216–234, 2012. View at Google Scholar
  3. G. Calviello, S. Serini, and P. Palozza, “n-3 polyunsaturated fatty acids as signal transduction modulators and therapeutical agents in cancer,” Current Signal Transduction Therapy, vol. 1, pp. 255–271, 2006. View at Google Scholar
  4. G. Calviello, S. Serini, E. Piccioni, and G. Pessina, “Antineoplastic effects of N-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies,” Nutrition and Cancer, vol. 61, no. 3, pp. 287–301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Calviello, S. Serini, and E. Piccioni, “Alzheimer's disease and n-3 polyunsaturated fatty acids: beneficial effects and possible molecular pathways involved,” Current Signal Transduction Therapy, vol. 3, no. 3, pp. 152–157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. H. M. Su, “Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance,” Journal of Nutritional Biochemistry, vol. 21, no. 5, pp. 364–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. B. Sawyer and C. J. Field, “Possible mechanism of ω-3PUFA anti-tumor action,” in Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer, G. Calviello, S. Serini, and A. Albini, Eds., vol. 1 of Diet and Cancer, pp. 3–27, Springer, London, UK, 2010. View at Google Scholar
  8. E. Fasano, S. Serini, E. Piccioni, and G. Calviello, “Chemoprevention of lung pathologies by dietary n-3 polyunsaturated fatty acids,” Current Medicinal Chemistry, vol. 17, no. 29, pp. 3358–3376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. C. Calder, “Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?” British Journal of Clinical Pharmacology, vol. 75, no. 3, pp. 645–662, 2013. View at Google Scholar
  10. E. A. Miles and P. C. Calder, “Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis,” British Journal of Nutrition, vol. 107, no. 2, supplement, pp. S171–S184, 2012. View at Google Scholar
  11. A. Belluzzi, “n-3 fatty acids for the treatment of inflammatory bowel diseases,” Proceedings of the Nutrition Society, vol. 61, no. 3, pp. 391–395, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Cabré, M. Mañosa, and M. A. Gassull, “Omega-3 fatty acids and inflammatory bowel diseases—a systematic review,” British Journal of Nutrition, vol. 107, no. 2, supplement, pp. S240–S252, 2012. View at Google Scholar
  13. R. McPherson and R. W. Davies, “Inflammation and coronary artery disease: insights from genetic studies,” Canadian Journal of Cardiology, vol. 28, no. 6, pp. 662–666, 2012. View at Google Scholar
  14. J. P. Després, “Abdominal obesity and cardiovascular disease: is inflammation the missing link?” Canadian Journal of Cardiology, vol. 28, no. 6, pp. 642–652, 2012. View at Google Scholar
  15. M. Verri, O. Pastoris, M. Dossena et al., “Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer’s disease,” International Journal of Immunopathology & Pharmacology, vol. 25, no. 2, pp. 345–353, 2012. View at Google Scholar
  16. C. Porta, P. Larghi, M. Rimoldi et al., “Cellular and molecular pathways linking inflammation and cancer,” Immunobiology, vol. 214, no. 9-10, pp. 761–777, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. B. M. Anderson and D. W. L. Ma, “Are all n-3 polyunsaturated fatty acids created equal?” Lipids in Health and Disease, vol. 8, article 33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H. M. Su, A. B. Moser, H. W. Moser, and P. A. Watkins, “Peroxisomal straight-chain Acyl-CoA oxidase and D-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis,” Journal of Biological Chemistry, vol. 276, no. 41, pp. 38115–38120, 2001. View at Google Scholar · View at Scopus
  19. N. Hussein, E. Ah-Sing, P. Wilkinson, C. Leach, B. A. Griffin, and D. J. Millward, “Long-chain conversion of [13C]linoleic acid and α-linolenic acid in response to marked changes in their dietary intake in men,” Journal of Lipid Research, vol. 46, no. 2, pp. 269–280, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. H. Weylandt, C. Y. Chiu, B. Gomolka, S. F. Waechter, and B. Wiedenmann, “Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation,” Prostaglandins & Other Lipid Mediators, vol. 97, no. 3-4, pp. 73–82, 2012. View at Google Scholar
  21. K. H. Weylandt and J. X. Kang, “Rethinking lipid mediators,” Lancet, vol. 366, no. 9486, pp. 618–620, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. W. J. Lukiw, J. G. Cui, V. L. Marcheselli et al., “A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease,” Journal of Clinical Investigation, vol. 115, no. 10, pp. 2774–2783, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. P. K. Mukherjee, V. L. Marcheselli, J. C. D. R. Vaccari, W. C. Gordon, F. E. Jackson, and N. G. Bazan, “Photoreceptor outer segment phagocytosis attenuates oxidative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 32, pp. 13158–13163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. X. Kang, J. Wang, L. Wu, and Z. B. Kang, “Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids,” Nature, vol. 427, no. 6974, p. 504, 2004. View at Google Scholar · View at Scopus
  25. C. A. Hudert, K. H. Weylandt, Y. Lu et al., “Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 30, pp. 11276–11281, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Gravaghi, K. M. D. La Perle, P. Ogrodwski et al., “Cox-2 expression, PGE2 and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice,” Journal of Nutritional Biochemistry, vol. 22, no. 4, pp. 360–365, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Belluzzi, C. Brignola, M. Campieri, A. Pera, S. Boschi, and M. Miglioli, “Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease,” New England Journal of Medicine, vol. 334, no. 24, pp. 1557–1560, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. B. G. Feagan, W. J. Sandborn, U. Mittmann et al., “Omega-3 free fatty acids for the maintenance of remission in crohn disease: the EPIC randomized controlled trials,” Journal of the American Medical Association, vol. 299, no. 14, pp. 1690–1697, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Turner, A. H. Steinhart, and A. M. Griffiths, “Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD006443, 2007. View at Google Scholar · View at Scopus
  30. C. Schmöcker, K. H. Weylandt, L. Kahlke et al., “Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines,” Hepatology, vol. 45, no. 4, pp. 864–869, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. K. H. Weylandt, L. F. Krause, B. Gomolka et al., “Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-α,” Carcinogenesis, vol. 32, no. 6, pp. 897–903, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. A. González-Périz, A. Planagumà, K. Gronert et al., “Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA,” The FASEB Journal, vol. 20, no. 14, pp. 2537–2539, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. E. H. Kim, J. S. Bae, K. B. Hahm, and J. Y. Cha, “Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease,” Biochemical Pharmacology, vol. 84, no. 10, pp. 1359–1365, 2012. View at Google Scholar
  34. A. González-Périz, R. Horrillo, N. Ferré et al., “Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins,” FASEB Journal, vol. 23, no. 6, pp. 1946–1957, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. H. D. Le, V. E. de Meijer, E. M. Robinson et al., “Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children,” The American Journal of Clinical Nutrition, vol. 94, no. 3, pp. 749–758, 2011. View at Google Scholar
  36. C. J. Glueck, N. Khan, M. Riaz, J. Padda, Z. Khan, and P. Wang, “Titrating lovaza from 4 to 8 to 12 grams/day in patients with primary hypertriglyceridemia who had triglyceride levels >500 mg/dl despite conventional triglyceride lowering therapy,” Lipids in Health and Disease, vol. 11, p. 143, 2012. View at Google Scholar
  37. W. S. Harris, D. W. Rothrock, A. Fanning et al., “Fish oils in hypertriglyceridemia: a dose-response study,” American Journal of Clinical Nutrition, vol. 51, no. 3, pp. 399–406, 1990. View at Google Scholar · View at Scopus
  38. B. E. Phillipson, D. W. Rothrock, W. E. Connor, W. S. Harris, and D. R. Illingworth, “Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia,” New England Journal of Medicine, vol. 312, no. 19, pp. 1210–1216, 1985. View at Google Scholar · View at Scopus
  39. B. Lindkvist, S. Appelros, S. Regner, and J. Manjer, “A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose,” Pancreatology, vol. 12, no. 4, pp. 317–324, 2012. View at Google Scholar
  40. M. H. Murad, A. Hazem, F. Coto-Yglesias et al., “The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis,” BMC Endocrine Disorders, vol. 12, article 2, 2012. View at Google Scholar
  41. K. H. Weylandt, A. Nadolny, L. Kahlke et al., “Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis,” Biochimica et Biophysica Acta, vol. 1782, no. 11, pp. 634–641, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Lasztity, J. Hamvas, L. Biró et al., “Effect of enterally administered n-3 polyunsaturated fatty acids in acute pancreatitis—a prospective randomized clinical trial,” Clinical Nutrition, vol. 24, no. 2, pp. 198–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. X. Wang, W. Li, N. Li, and J. Li, “ω-3 fatty acids—supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study,” Journal of Parenteral and Enteral Nutrition, vol. 32, no. 3, pp. 236–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Puri, R. A. Baillie, M. M. Wiest et al., “A lipidomic analysis of nonalcoholic fatty liver disease,” Hepatology, vol. 46, no. 4, pp. 1081–1090, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Puri, M. M. Wiest, O. Cheung et al., “The plasma lipidomic signature of nonalcoholic steatohepatitis,” Hepatology, vol. 50, no. 6, pp. 1827–1838, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Gomolka, E. Siegert, K. Blossey, W. H. Schunck, M. Rothe, and K. H. Weylandt, “Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples,” Prostaglandins and Other Lipid Mediators, vol. 94, no. 3-4, pp. 81–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. P. S. Sastry, “Lipids of nervous tissue: composition and metabolism,” Progress in Lipid Research, vol. 24, no. 2, pp. 69–176, 1985. View at Google Scholar · View at Scopus
  48. J. Dobbing and J. Sands, “Comparative aspects of the brain growth spurt,” Early Human Development, vol. 3, no. 1, pp. 79–83, 1979. View at Google Scholar · View at Scopus
  49. P. Green, S. Glozman, B. Kamensky, and E. Yavin, “Developmental changes in rat brain membrane lipids and fatty acids: the preferential prenatal accumulation of docosahexaenoic acid,” Journal of Lipid Research, vol. 40, no. 5, pp. 960–966, 1999. View at Google Scholar · View at Scopus
  50. M. Martinez, “Tissue levels of polyunsaturated fatty acids during early human development,” Journal of Pediatrics, vol. 120, no. 4, pp. 129–138, 1992. View at Google Scholar · View at Scopus
  51. S. Favrelière, S. Stadelmann-Ingrand, F. Huguet et al., “Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus,” Neurobiology of Aging, vol. 21, no. 5, pp. 653–660, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Delion, S. Chalon, D. Guilloteau, B. Lejeune, J. C. Besnard, and G. Durand, “Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet,” Journal of Lipid Research, vol. 38, no. 4, pp. 680–689, 1997. View at Google Scholar · View at Scopus
  53. M. Soderberg, C. Edlund, K. Kristensson, and G. Dallner, “Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease,” Lipids, vol. 26, no. 6, pp. 421–425, 1991. View at Google Scholar · View at Scopus
  54. M. R. Prasad, M. A. Lovell, M. Yatin, H. Dhillon, and W. R. Markesbery, “Regional membrane phospholipid alterations in Alzheimer's disease,” Neurochemical Research, vol. 23, no. 1, pp. 81–88, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. W. L. Chung, J. J. Chen, and H. M. Su, “Fish oil supplementation of control and (n-3) fatty acid-deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels,” Journal of Nutrition, vol. 138, no. 6, pp. 1165–1171, 2008. View at Google Scholar · View at Scopus
  56. A. M. Tully, H. M. Roche, R. Doyle et al., “Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study,” British Journal of Nutrition, vol. 89, no. 4, pp. 483–489, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. B. L. Scott and N. G. Bazan, “Membrane docosahexaenoate is supplied to the developing brain and retina by the liver,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 8, pp. 2903–2907, 1989. View at Google Scholar · View at Scopus
  58. P. Green and E. Yavin, “Elongation, desaturation, and esterification of essential fatty acids by fetal rat brain in vivo,” Journal of Lipid Research, vol. 34, no. 12, pp. 2099–2107, 1993. View at Google Scholar · View at Scopus
  59. H. M. Su, M. C. Huang, N. M. R. Saad, P. W. Nathanielsz, and J. T. Brenna, “Fetal baboons convert 18:3n-3 to 22:6n-3 in vivo: a stable isotope tracer study,” Journal of Lipid Research, vol. 42, no. 4, pp. 581–586, 2001. View at Google Scholar · View at Scopus
  60. C. M. Williams and G. Burdge, “Long-chain n-3 PUFA: plant v. marine sources,” Proceedings of the Nutrition Society, vol. 65, no. 1, pp. 42–50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. J. T. Brenna, N. Salem Jr., A. J. Sinclair, and S. C. Cunnane, “α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 80, no. 2-3, pp. 85–91, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. P. K. Mukherjee, V. L. Marcheselli, C. N. Serhan, and N. G. Bazan, “Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 22, pp. 8491–8496, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Y. Kim, M. Akbar, A. Lau, and L. Edsall, “Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3): role of phosphatidylserine in antiapoptotic effect,” Journal of Biological Chemistry, vol. 275, no. 45, pp. 35215–35223, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Akbar and H. Y. Kim, “Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway,” Journal of Neurochemistry, vol. 82, no. 3, pp. 655–665, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Akbar, F. Calderon, Z. Wen, and H. Y. Kim, “Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 31, pp. 10858–10863, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. N. P. Rotstein, L. E. Politi, O. L. German, and R. Girotti, “Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors,” Investigative Ophthalmology and Visual Science, vol. 44, no. 5, pp. 2252–2259, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. N. P. Rotstein, M. I. Aveldańo, F. J. Barrantes, A. M. Roccamo, and L. E. Politi, “Apoptosis of retinal photoreceptors during development in vitro: protective effect of docosahexaenoic acid,” Journal of Neurochemistry, vol. 69, no. 2, pp. 504–513, 1997. View at Google Scholar · View at Scopus
  68. I. Lauritzen, N. Blondeau, C. Heurteaux, C. Widmann, G. Romey, and M. Lazdunski, “Polyunsaturated fatty acids are potent neuroprotectors,” EMBO Journal, vol. 19, no. 8, pp. 1784–1793, 2000. View at Google Scholar · View at Scopus
  69. A. M. Lynch, D. J. Loane, A. M. Minogue et al., “Eicosapentaenoic acid confers neuroprotection in the amyloid-β challenged aged hippocampus,” Neurobiology of Aging, vol. 28, no. 6, pp. 845–855, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. D. M. Walsh and D. J. Selkoe, “Aβ oligomers—a decade of discovery,” Journal of Neurochemistry, vol. 101, no. 5, pp. 1172–1184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Mulder, P. Scheltens, J. J. Visser, G. J. Van Kamp, and R. B. H. Schutgens, “Genetic and biochemical markers for Alzheimer's disease: recent developments,” Annals of Clinical Biochemistry, vol. 37, no. 5, pp. 593–607, 2000. View at Google Scholar · View at Scopus
  72. M. Rapoport, H. N. Dawson, L. I. Binder, M. P. Vitek, and A. Ferreira, “Tau is essential to β-amyloid-induced neurotoxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 9, pp. 6364–6369, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. T. L. Spires and B. T. Hyman, “Transgenic models of Alzheimer's disease: learning from animals,” NeuroRx, vol. 2, no. 3, pp. 423–437, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. H. Braak and E. Braak, “Frequency of stages of Alzheimer-related lesions in different age categories,” Neurobiology of Aging, vol. 18, no. 4, pp. 351–357, 1997. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Hossain, M. Hashimoto, M. Katakura, K. Miwa, T. Shimada, and O. Shido, “Mechanism of docosahexaenoic acid-induced inhibition of in vitro Aβ1-42 fibrillation and Aβ1-42-induced toxicity in SH-S5Y5 cells,” Journal of Neurochemistry, vol. 111, no. 2, pp. 568–579, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. Zhao, F. Calon, C. Julien et al., “Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models,” PLoS ONE, vol. 6, no. 1, Article ID e15816, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. P. K. Mukherjee, V. L. Marcheselli, S. Barreiro, J. Hu, D. Bok, and N. G. Bazan, “Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 32, pp. 13152–13157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. G. P. Lim, F. Calon, T. Morihara et al., “A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model,” Journal of Neuroscience, vol. 25, no. 12, pp. 3032–3040, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. K. N. Green, H. Martinez-Coria, H. Khashwji et al., “Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-β and tau pathology via a mechanism involving presenilin 1 levels,” Journal of Neuroscience, vol. 27, no. 16, pp. 4385–4395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Hashimoto, S. Hossain, T. Shimada et al., “Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats,” Journal of Neurochemistry, vol. 81, no. 5, pp. 1084–1091, 2002. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Hashimoto, Y. Tanabe, Y. Fujii, T. Kikuta, H. Shibata, and O. Shido, “Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid β-infused rats,” Journal of Nutrition, vol. 135, no. 3, pp. 549–555, 2005. View at Google Scholar · View at Scopus
  82. M. Hashimoto, S. Hossain, Y. Tanabe et al., “The protective effect of dietary eicosapentaenoic acid against impairment of spatial cognition learning ability in rats infused with amyloid β(1-40),” Journal of Nutritional Biochemistry, vol. 20, no. 12, pp. 965–973, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. F. Calon, G. P. Lim, F. Yang et al., “Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model,” Neuron, vol. 43, no. 5, pp. 633–645, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Freund-Levi, M. Eriksdotter-Jönhagen, T. Cederholm et al., “ω-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: omegAD study—a randomized double-blind trial,” Archives of Neurology, vol. 63, no. 10, pp. 1402–1408, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. I. Vedin, T. Cederholm, Y. F. Levi et al., “Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study,” American Journal of Clinical Nutrition, vol. 87, no. 6, pp. 1616–1622, 2008. View at Google Scholar · View at Scopus
  86. I. Vedin, T. Cederholm, Y. Freund-Levi et al., “Reduced prostaglandin F2α release from blood mononuclear leukocytes after oral supplementation of ω3 fatty acids: the OmegAD study,” Journal of Lipid Research, vol. 51, no. 5, pp. 1179–1185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. I. Vedin, T. Cederholm, Y. F. Levi et al., “Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study,” PLoS ONE, vol. 7, no. 4, Article ID e35425, 2012. View at Google Scholar
  88. Y. Freund-Levi, E. Hjorth, C. Lindberg et al., “Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in alzheimer's disease: the omegad study,” Dementia and Geriatric Cognitive Disorders, vol. 27, no. 5, pp. 481–490, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. M. A. Beydoun, J. S. Kaufman, J. A. Satia, W. Rosamond, and A. R. Folsom, “Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the atherosclerosis risk in communities study,” American Journal of Clinical Nutrition, vol. 85, no. 4, pp. 1103–1111, 2007. View at Google Scholar · View at Scopus
  90. L. J. Whalley, I. J. Deary, J. M. Starr et al., “n-3 Fatty acid erythrocyte membrane content, APOE ε4, and cognitive variation: an observational follow-up study in late adulthood,” American Journal of Clinical Nutrition, vol. 87, no. 2, pp. 449–454, 2008. View at Google Scholar · View at Scopus
  91. C. Boudrault, R. P. Bazinet, and D. W. L. Ma, “Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease,” Journal of Nutritional Biochemistry, vol. 20, no. 1, pp. 1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Hashimoto, K. Yamashita, S. Kato et al., “Beneficial effects of dietary omega-3 polyunsaturated fatty acid supplementation on age-related cognitive decline in elder Japanese with very mild dementia: a 2-year randomized, double-blind, placebo-controlled trial,” Journal of Aging Research and Clinical Practice, vol. 1, no. 3, pp. 193–201, 2012. View at Google Scholar
  93. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. N. B. Janakiram, A. Mohammed, and C. V. Rao, “Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer,” Cancer and Metastasis Reviews, vol. 30, no. 3-4, pp. 507–523, 2011. View at Google Scholar
  95. C. Berasain, M. J. Perugorria, M. U. Latasa et al., “The epidermal growth factor receptor: a link between inflammation and liver cancer,” Experimental Biology and Medicine, vol. 234, no. 7, pp. 713–725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. F. R. Balkwill and A. Mantovani, “Cancer-related inflammation: common themes and therapeutic opportunities,” Seminars in Cancer Biology, vol. 22, no. 1, pp. 33–40, 2012. View at Google Scholar
  97. A. Manzano A and P. Pérez-Segura, “Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?” ScientificWorldJournal, vol. 2012, Article ID 327341, 8 pages, 2012. View at Publisher · View at Google Scholar
  98. D. W. Kamp, E. Shacter, and S. A. Weitzman, “Chronic inflammation and cancer: the role of the mitochondria,” Oncology, vol. 25, no. 5, pp. 400–413, 2011. View at Google Scholar · View at Scopus
  99. H. Ohshima, H. Tazawa, B. S. Sylla, and T. Sawa, “Prevention of human cancer by modulation of chronic inflammatory processes,” Mutation Research, vol. 591, no. 1-2, pp. 110–122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Sica, P. Larghi, A. Mancino et al., “Macrophage polarization in tumour progression,” Seminars in Cancer Biology, vol. 18, no. 5, pp. 349–355, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica, “Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes,” Trends in Immunology, vol. 23, no. 11, pp. 549–555, 2002. View at Publisher · View at Google Scholar · View at Scopus
  102. C. L. L. Saw, Y. Huang, and A. N. Kong, “Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid,” Biochemical Pharmacology, vol. 79, no. 3, pp. 421–430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. J. M. Monk, T. Y. Hou, H. F. Turk et al., “Dietary n-3 polyunsaturated fatty acids (PUFA) decrease obesity-associated Th17 cell-mediated inflammation during colitis,” PLoS ONE, vol. 7, no. 11, Article ID e49739, 2012. View at Google Scholar
  104. A. L. Brown, X. Zhu, S. Rong et al., “Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions,” Arteriosclerosis, Thrombosis and Vascular Biology, vol. 32, no. 9, pp. 2122–2130, 2012. View at Google Scholar
  105. G. Calviello and S. Serini, “ω-3 PUFAs, why are we speaking of them?” in Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer, G. Calviello, S. Serini, and A. Albini, Eds., vol. 1 of Diet and Cancer, pp. 9–21, Springer, London, UK, 2010. View at Google Scholar
  106. C. Finocchiaro, O. Segre, M. Fadda et al., “Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study,” British Journal of Nutrition, vol. 108, no. 2, pp. 327–333, 2012. View at Google Scholar
  107. M. W. Zhu, D. N. Tang, J. Hou et al., “Impact of fish oil enriched total parenteral nutrition on elderly patients after colorectal cancer surgery,” Chinese Medicine Journal, vol. 125, no. 2, pp. 178–181, 2012. View at Google Scholar
  108. J. A. Read, P. J. Beale, D. H. Volker, N. Smith, A. Childs, and S. J. Clarke, “Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial,” Supportive Care in Cancer, vol. 15, no. 3, pp. 301–307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. Y. R. Lou, Q. Y. Peng, T. Li et al., “Effects of high-fat diets rich in either omega-3 or omega-6 fatty acids on UVB-induced skin carcinogenesis in SKH-1 mice,” Carcinogenesis, vol. 32, no. 7, pp. 1078–1084, 2011. View at Publisher · View at Google Scholar · View at Scopus
  110. K. S. Park, J. W. Lim, and H. Kim, “Inhibitory mechanism of omega-3 fatty acids in pancreatic inflammation and apoptosis,” Annals of the New York Academy of Sciences, vol. 1171, pp. 421–427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. D. D. Rosa, F. C. Lourenço, A. C. da Fonseca et al., “Fish oil improves the lipid profile and reduces inflammatory cytokines in Wistar rats with precancerous colon lesions,” Nutrition and Cancer, vol. 64, no. 4, pp. 569–579, 2012. View at Google Scholar
  112. S. Serini, E. Piccioni, and G. Calviello, “ω-3 PUFAs and colon cancer: experimental studies and human interventional trials,” in Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer, G. Calviello, S. Serini, and A. Albini, Eds., vol. 1 of Diet and Cancer, pp. 67–89, Springer, London, UK, 2010. View at Google Scholar
  113. A. Ibrahim, K. Mbodji, A. Hassan et al., “Anti-inflammatory and anti-angiogenic effect of long chain n-3 polyunsaturated fatty acids in intestinal microvascular endothelium,” Clinical Nutrition, vol. 30, no. 5, pp. 678–687, 2011. View at Google Scholar
  114. G. Calviello, F. Di Nicuolo, S. Gragnoli et al., “n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1α induction pathway,” Carcinogenesis, vol. 25, no. 12, pp. 2303–2310, 2004. View at Publisher · View at Google Scholar · View at Scopus
  115. A. Storey, F. McArdle, P. S. Friedmann, M. J. Jackson, and L. E. Rhodes, “Eicosapentaenoic acid and docosahexaenoic acid reduce UVB- and TNF-α-induced IL-8 secretion in keratinocytes and UVB-induced IL-8 in fibroblasts,” Journal of Investigative Dermatology, vol. 124, no. 1, pp. 248–255, 2005. View at Publisher · View at Google Scholar · View at Scopus
  116. M. Bögels, R. Braster, P. G. Nijland et al., “Carcinoma origin dictates differential skewing of monocyte function,” Oncoimmunology, vol. 1, no. 6, pp. 798–809, 2012. View at Google Scholar
  117. C. Y. Chiu, B. Gomolka, C. Dierkes et al., “Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis,” Inflammation Research, vol. 61, no. 9, pp. 967–976, 2012. View at Google Scholar
  118. X. Dolcet, D. Llobet, J. Pallares, and X. Matias-Guiu, “NF-kB in development and progression of human cancer,” Virchows Archiv, vol. 446, no. 5, pp. 475–482, 2005. View at Publisher · View at Google Scholar · View at Scopus
  119. E. Pikarsky, R. M. Porat, I. Stein et al., “NF-κB functions as a tumour promoter in inflammation-associated cancer,” Nature, vol. 431, no. 7007, pp. 461–466, 2004. View at Publisher · View at Google Scholar · View at Scopus
  120. A. Saccani, T. Schioppa, C. Porta et al., “p50 nuclear factor-κB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance,” Cancer Research, vol. 66, no. 23, pp. 11432–11440, 2006. View at Publisher · View at Google Scholar · View at Scopus
  121. J. Nowak, K. H. Weylandt, P. Habbel et al., “Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids,” Carcinogenesis, vol. 28, no. 9, pp. 1991–1995, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. Q. Jia, J. R. Lupton, R. Smith et al., “Reduced colitis-associated colon cancer in fat-1 (n-3 fatty acid desaturase) transgenic mice,” Cancer Research, vol. 68, no. 10, pp. 3985–3991, 2008. View at Publisher · View at Google Scholar · View at Scopus
  123. J. Griffitts, D. Saunders, Y. A. Tesiram et al., “Non-mammalian fat-1 gene prevents neoplasia when introduced to a mouse hepatocarcinogenesis model. Omega-3 fatty acids prevent liver neoplasia,” Biochimica et Biophysica Acta, vol. 1801, no. 10, pp. 1133–1144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. G. Sethi, M. K. Shanmugam, L. Ramachandran, A. P. Kumar, and V. Tergaonkar, “Multifaceted link between cancer and inflammation,” Bioscience Reports, vol. 32, no. 1, pp. 1–15, 2012. View at Google Scholar
  125. S. Serini, V. Donato, E. Piccioni et al., “Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR,” Journal of Nutritional Biochemistry, vol. 22, no. 9, pp. 874–885, 2011. View at Google Scholar
  126. S. Serini, E. Fasano, E. Piccioni et al., “DHA induces apoptosis and differentiation in human melanoma cells in vitro: involvement of HuR-mediated COX-2 mRNA stabilization and β-catenin nuclear translocation,” Carcinogenesis, vol. 33, no. 1, pp. 164–173, 2012. View at Google Scholar
  127. G. Solinas, F. Marchesi, C. Garlanda, A. Mantovani, and P. Allavena, “Inflammation-mediated promotion of invasion and metastasis,” Cancer and Metastasis Reviews, vol. 29, no. 2, pp. 243–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  128. R. Giavazzi, A. Garofalo, M. R. Bani et al., “Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice,” Cancer Research, vol. 50, no. 15, pp. 4771–4775, 1990. View at Google Scholar · View at Scopus
  129. H. H. Kim, Y. Lee, H. C. Eun, and J. H. Chung, “Eicosapentaenoic acid inhibits TNF-α-induced matrix metalloproteinase-9 expression in human keratinocytes, HaCaT cells,” Biochemical and Biophysical Research Communications, vol. 368, no. 2, pp. 343–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. E. J. Bernhard, S. B. Gruber, and R. J. Muschel, “Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 10, pp. 4293–4297, 1994. View at Google Scholar · View at Scopus
  131. S. Zucker, R. M. Lysik, M. H. Zarrabi, and U. Moll, “M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer,” Cancer Research, vol. 53, no. 1, pp. 140–146, 1993. View at Google Scholar · View at Scopus
  132. W. Cao, Z. Ma, M. M. Rasenick, S. Yeh, and J. Yu, “N-3 poly-unsaturated Fatty acids shift estrogen signaling to inhibit human breast cancer cell growth,” PLoS ONE, vol. 7, no. 12, Article ID e52838, 2012. View at Google Scholar
  133. K. R. Rogers, K. D. Kikawa, M. Mouradian et al., “Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association,” Carcinogenesis, vol. 31, no. 9, pp. 1523–1530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Sharma, J. Belna, J. Espat, G. Rodriguez, V. T. Cannon, and J. A. Hurteau, “Effects of omega-3 fatty acids on components of the transforming growth factor beta-1 pathway: implication for dietary modification and prevention in ovarian cancer,” American Journal of Obstetrics and Gynecology, vol. 200, no. 5, pp. 516.e1–516.e6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  135. M. Bitzer, G. Von Gersdorff, D. Liang et al., “A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA,” Genes and Development, vol. 14, no. 2, pp. 187–197, 2000. View at Google Scholar · View at Scopus
  136. G. Calviello, S. Serini, E. Piccioni, and G. Pessina, “Antineoplastic effects of N-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies,” Nutrition and Cancer, vol. 61, no. 3, pp. 287–301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  137. M. B. Sawyer and C. J. Field, “Possible mechanisms of omega-3 (n-3) PUFA anti-tumour action,” in Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer, G. Calviello, S. Serini, and A. Albini, Eds., vol. 1 of Diet and Cancer, pp. 3–38, Springer, London, UK, 2010. View at Google Scholar
  138. E. Fasano, S. Serini, E. Piccioni et al., “DHA induces apoptosis by altering the expression and cellular location of GRP78 in colon cancer cell lines,” Biochimica et Biophysica Acta, vol. 1822, no. 11, pp. 1762–1772, 2012. View at Google Scholar
  139. S. Serini, E. Fasano, E. Piccioni, A. R. Cittadini, and G. Calviello, “Differential anti-cancer effects of purified EPA and DHA and possible mechanisms involved,” Current Medicinal Chemistry, vol. 18, no. 26, pp. 4065–4075, 2011. View at Google Scholar
  140. G. Calviello, F. Resci, S. Serini et al., “Docosahexaenoic acid induces proteasome-dependent degradation of β-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2,” Carcinogenesis, vol. 28, no. 6, pp. 1202–1209, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. W. Stillwell and S. R. Wassall, “Docosahexaenoic acid: membrane properties of a unique fatty acid,” Chemistry and Physics of Lipids, vol. 126, no. 1, pp. 1–27, 2003. View at Publisher · View at Google Scholar · View at Scopus
  142. M. Anti, G. Marra, F. Armelao et al., “Effect of ω-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer,” Gastroenterology, vol. 103, no. 3, pp. 883–891, 1992. View at Google Scholar · View at Scopus
  143. Y. C. Huang, J. M. Jessup, R. A. Forse et al., “n-3 fatty acids decrease colonic epithelial cell proliferation in high-risk bowel mucosa,” Lipids, vol. 31, no. 3, supplement, pp. S313–S317, 1996. View at Google Scholar · View at Scopus
  144. N. J. West, S. K. Clark, R. K. S. Phillips et al., “Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis,” Gut, vol. 59, no. 7, pp. 918–925, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. N. Sawada, M. Inoue, M. Iwasaki et al., “Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma,” Gastroenterology, vol. 142, no. 7, pp. 1468–1475, 2012. View at Google Scholar